Johnson & Johnson Issues Alert for Impella Heart Pump Controllers After Fatalities and Injuries

Johnson & Johnson has issued an early alert for customers to remove automated Impella heart pump controllers due to component failures. The FDA has linked these failures to three deaths and 37 serious injuries, prompting hospitals to use existing inventory while awaiting service from J&J's Abiomed business.